Intravenous and oral pharmacokinetic study of BCX-1777, a novel purine nucleoside phosphorylase transition-state inhibitor. In vivo effects on blood 2′-deoxyguanosine in primates (Q44399718)
Jump to navigation
Jump to search
scientific article published on April 1, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intravenous and oral pharmacokinetic study of BCX-1777, a novel purine nucleoside phosphorylase transition-state inhibitor. In vivo effects on blood 2′-deoxyguanosine in primates |
scientific article published on April 1, 2003 |
Statements
1 reference
Intravenous and oral pharmacokinetic study of BCX-1777, a novel purine nucleoside phosphorylase transition-state inhibitor. In vivo effects on blood 2'-deoxyguanosine in primates (English)
1 reference
Intravenous and oral pharmacokinetic study of BCX-1777, a novel purine nucleoside phosphorylase transition-state inhibitor. In vivo effects on blood 2′-deoxyguanosine in primates (English)
1 reference
1 reference
1 reference
Deborah Phillips
1 reference
J. Michael Kilpatrick
Philip E. Morris
David G. Serota
D. Ray Moore
J. Claude Bennett
1 April 2003
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference